Among the more than 11 000 patients taking pioglitazone (Actos), the physical body risks of apoplexy and MI were lower than that of the >55 000 patients taking other diabetes drugs, even after calibration for age, physiological concept, hypertension, hyperlipidemia, meat nonstarter, edema, use of concurrent antidiabetic drugs, antiplatelet drugs, and lipid-lowering drugs.
Fate ratios vs nonthiazolidinedione drugs End linear measuring device Pioglitazone 95% CI Mark mark
0.800.72
This is a part of article The person risks of apoplexy. Taken from "Actos Pioglitazone" Information Blog
Tuesday, March 4, 2008
The person risks of apoplexy.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment